119 related articles for article (PubMed ID: 2544477)
1. [Hormone dependence of malignant ovarian tumors--an in vitro model].
Schieder K; Bieglmayer C; Kölbl H
Geburtshilfe Frauenheilkd; 1989 May; 49(5):437-41. PubMed ID: 2544477
[TBL] [Abstract][Full Text] [Related]
2. Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay.
Osborne CK; Von Hoff DD; Mullins K
Breast Cancer Res Treat; 1985; 6(3):229-35. PubMed ID: 2936413
[TBL] [Abstract][Full Text] [Related]
3. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
Nomura Y; Tashiro H; Takaeko F
Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
[TBL] [Abstract][Full Text] [Related]
4. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M
Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035
[TBL] [Abstract][Full Text] [Related]
5. Steroid receptors and response of endometrial cancer to hormones in vitro.
Grönroos M; Mäenpää J; Kangas L; Erkkola R; Paul R; Grenman S
Ann Chir Gynaecol Suppl; 1987; 202():76-9. PubMed ID: 2959189
[TBL] [Abstract][Full Text] [Related]
6. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
7. [Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
Okada H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):924-8. PubMed ID: 2968780
[TBL] [Abstract][Full Text] [Related]
8. Experimental endocrinotherapy with tamoxifen of human ovarian dysgerminoma transplanted into nude mice.
Isonishi S
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2185-92. PubMed ID: 3429992
[TBL] [Abstract][Full Text] [Related]
9. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
Tominaga T; Yoshida Y; Kitamura M; Kosaki G
Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
[TBL] [Abstract][Full Text] [Related]
10. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
Thurzó L
Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
[TBL] [Abstract][Full Text] [Related]
11. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
Jpn J Cancer Res; 1989 Mar; 80(3):244-8. PubMed ID: 2524460
[TBL] [Abstract][Full Text] [Related]
12. [Value of the tumor colony assay in therapy planning in malignant ovarian tumors].
Schieder K; Kölbl H; Bieglmayer C
Geburtshilfe Frauenheilkd; 1987 Jan; 47(1):41-4. PubMed ID: 3569826
[TBL] [Abstract][Full Text] [Related]
13. In vitro responsiveness of ovarian epithelial carcinomas to endocrine therapy.
Runge HM; Teufel G; Neulen J; Geyer H; Pfleiderer A
Cancer Chemother Pharmacol; 1986; 16(1):58-63. PubMed ID: 2933176
[TBL] [Abstract][Full Text] [Related]
14. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
15. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
[TBL] [Abstract][Full Text] [Related]
16. The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitro.
Geisinger KR; Berens ME; Duckett Y; Morgan TM; Kute TE; Welander CE
Cancer; 1990 Mar; 65(5):1055-61. PubMed ID: 2137365
[TBL] [Abstract][Full Text] [Related]
17. Endocrine factors in common epithelial ovarian cancer.
Rao BR; Slotman BJ
Endocr Rev; 1991 Feb; 12(1):14-26. PubMed ID: 1851084
[TBL] [Abstract][Full Text] [Related]
18. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
Katsuki Y; Shibutani Y; Aoki D; Nozawa S
Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742
[TBL] [Abstract][Full Text] [Related]
19. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
[TBL] [Abstract][Full Text] [Related]
20. A study of estrogen and progesterone cytosol receptor concentration in benign and malignant ovarian tumors and a review of malignant ovarian tumors treated with medroxy-progesterone acetate.
Bergqvist A; Kullander S; Thorell J
Acta Obstet Gynecol Scand Suppl; 1981; 101():75-81. PubMed ID: 6946676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
